NEW YORK (Reuters Health) – A retrospective multicenter study conducted in France concludes that combination chemotherapy with gemcitabine and oxaliplatin is effective in patients with advanced hepatocellular carcinoma…
NEW YORK (Reuters Health) – In the first-line treatment of advanced colorectal cancer, the combination of cediranib and chemotherapy is comparable to bevacizumab plus chemotherapy in terms of…
Ambulatory surgical centers (ASC) are facilities that aim to combine the best healthcare providers, the latest medical equipment, and the most efficient outpatient services. Leslie Seecoomar, MD, describes how expanding…
NEW YORK (Reuters Health) – There is “sufficient” evidence that treatment with a proton-pump inhibitor (PPI) increases the incidence of Clostridium-difficile-associated diarrhea (CDAD), say the authors of a…
NEW YORK (Reuters Health) – Serrated lesions of the colorectum, once thought benign, may give rise to one-third of all colorectal cancers, but are more difficult to detect…
NEW YORK (Reuters Health) – Blood from patients with uncomplicated hemochromatosis is safe and effective for transfusion, researchers from the Belgian Red Cross report in the June 1st…
NEW YORK (Reuters Health) – Cap-assisted colonoscopy (CAC) shortens cecal intubation time but offers only a marginal benefit over standard colonoscopy for polyp detection, according to a systematic…
NEW YORK (Reuters Health) – A strategy that combines cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) provides acceptable long term survival for patients with pseudomyxoma peritonei of appendiceal…
NEW YORK (Reuters Health) – Infliximab for inflammatory bowel disease (IBD) is not associated with an increased risk for serious infection, death, or malignancy, including lymphoma, according to…
NEW YORK (Reuters Health) – Generally, the accuracy of antigen-based point-of-care tests for hepatitis B infection is high, but the sensitivity of antibody-based tests needs to be improved,…